These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

500 related items for PubMed ID: 18852398

  • 1. Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects.
    Bays HE, Goldberg RB, Truitt KE, Jones MR.
    Arch Intern Med; 2008 Oct 13; 168(18):1975-83. PubMed ID: 18852398
    [Abstract] [Full Text] [Related]

  • 2. Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes.
    Zieve FJ, Kalin MF, Schwartz SL, Jones MR, Bailey WL.
    Clin Ther; 2007 Jan 13; 29(1):74-83. PubMed ID: 17379048
    [Abstract] [Full Text] [Related]

  • 3. Colesevelam hydrochloride added to background metformin therapy in patients with type 2 diabetes mellitus: a pooled analysis from 3 clinical studies.
    Bays HE.
    Endocr Pract; 2011 Jan 13; 17(6):933-8. PubMed ID: 21856592
    [Abstract] [Full Text] [Related]

  • 4. Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes.
    Rosenstock J, Fonseca VA, Garvey WT, Goldberg RB, Handelsman Y, Abby SL, Lai YL, Jin X, Misir S, Nagendran S, Jones MR.
    Endocr Pract; 2010 Jan 13; 16(4):629-40. PubMed ID: 20634175
    [Abstract] [Full Text] [Related]

  • 5. Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy.
    Fonseca VA, Rosenstock J, Wang AC, Truitt KE, Jones MR.
    Diabetes Care; 2008 Aug 13; 31(8):1479-84. PubMed ID: 18458145
    [Abstract] [Full Text] [Related]

  • 6. Initial combination therapy with metformin plus colesevelam improves lipoprotein particles in patients with early type 2 diabetes mellitus.
    Goldberg RB, Rosenson RS, Hernandez-Triana E, Misir S, Jones MR.
    J Clin Lipidol; 2012 Aug 13; 6(4):318-24. PubMed ID: 22836068
    [Abstract] [Full Text] [Related]

  • 7. Concomitant reduction in low-density lipoprotein cholesterol and glycated hemoglobin with colesevelam hydrochloride in patients with type 2 diabetes: a pooled analysis.
    Jialal I, Abby SL, Misir S, Nagendran S.
    Metab Syndr Relat Disord; 2009 Jun 13; 7(3):255-8. PubMed ID: 19344229
    [Abstract] [Full Text] [Related]

  • 8. An economic evaluation of colesevelam when added to metformin-, insulin- or sulfonylurea-based therapies in patients with uncontrolled type 2 diabetes mellitus.
    Simons WR, Hagan MA.
    Pharmacoeconomics; 2010 Jun 13; 28(9):765-80. PubMed ID: 20799756
    [Abstract] [Full Text] [Related]

  • 9. Effects of colesevelam, rosiglitazone, or sitagliptin on glycemic control and lipid profile in patients with type 2 diabetes mellitus inadequately controlled by metformin monotherapy.
    Rigby SP, Handelsman Y, Lai YL, Abby SL, Tao B, Jones MR.
    Endocr Pract; 2010 Jun 13; 16(1):53-63. PubMed ID: 19789153
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
    Goldberg RB, Fonseca VA, Truitt KE, Jones MR.
    Arch Intern Med; 2008 Jul 28; 168(14):1531-40. PubMed ID: 18663165
    [Abstract] [Full Text] [Related]

  • 11. Colesevelam HCl effects on atherogenic lipoprotein subclasses in subjects with type 2 diabetes.
    Rosenson RS, Abby SL, Jones MR.
    Atherosclerosis; 2009 Jun 28; 204(2):342-4. PubMed ID: 18996525
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of colesevelam in combination with pioglitazone in patients with type 2 diabetes mellitus.
    Rosenstock J, Truitt KE, Baz-Hecht M, Ford DM, Tao B, Chou HS.
    Horm Metab Res; 2014 Dec 28; 46(13):943-9. PubMed ID: 25054436
    [Abstract] [Full Text] [Related]

  • 13. The glucose and lipid effects of colesevelam as monotherapy in drug-naïve type 2 diabetes.
    Rosenstock J, Rigby SP, Ford DM, Tao B, Chou HS.
    Horm Metab Res; 2014 May 28; 46(5):348-53. PubMed ID: 24356792
    [Abstract] [Full Text] [Related]

  • 14. Effects of colesevelam on glucose absorption and hepatic/peripheral insulin sensitivity in patients with type 2 diabetes mellitus.
    Henry RR, Aroda VR, Mudaliar S, Garvey WT, Chou HS, Jones MR.
    Diabetes Obes Metab; 2012 Jan 28; 14(1):40-6. PubMed ID: 21831167
    [Abstract] [Full Text] [Related]

  • 15. Initial combination therapy with metformin plus colesevelam in drug-naïve Hispanic patients with early type 2 diabetes.
    Rosenstock J, Hernandez-Triana E, Handelsman Y, Misir S, Jones MR, Nagendran S.
    Postgrad Med; 2012 Jul 28; 124(4):7-13. PubMed ID: 22913889
    [Abstract] [Full Text] [Related]

  • 16. Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study.
    Handelsman Y, Goldberg RB, Garvey WT, Fonseca VA, Rosenstock J, Jones MR, Lai YL, Jin X, Misir S, Nagendran S, Abby SL.
    Endocr Pract; 2010 Jul 28; 16(4):617-28. PubMed ID: 20634176
    [Abstract] [Full Text] [Related]

  • 17. Rationale and design of a clinical trial to evaluate metformin and colesevelam HCl as first-line therapy in type 2 diabetes and colesevelam HCl in prediabetes.
    Jones MR, Mudaliar S, Hernandez-Triana E, Unnikrishnan AG, Lai YL, Abby SL, Misir S, Jin X, Nagendran S.
    Curr Med Res Opin; 2009 Sep 28; 25(9):2239-49. PubMed ID: 19622007
    [Abstract] [Full Text] [Related]

  • 18. Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study.
    Beysen C, Murphy EJ, Deines K, Chan M, Tsang E, Glass A, Turner SM, Protasio J, Riiff T, Hellerstein MK.
    Diabetologia; 2012 Feb 28; 55(2):432-42. PubMed ID: 22134839
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.